Fundraising FoxSynBioVen — Full Portfolio
7 tracked investments · listed companies and verified rows first
PartnerDavid Harding· solo GP
Co-investorsFuture Planet CapitalOxford Investment Opportunity Network (OION)
Colorifix uses engineered microorganisms to produce, deposit, and fix dyes on textiles through a biological fermentation process, aiming to reduce the environmental impact of textile dyeing.
BiotechCircular EconomyCleantechClimate TechNew MaterialsNorwich, GB
Orr Yarkoni(Founder)in
PartnerDavid Harding· solo GP
Co-investorsGOLDWIN VENTURE PARTNERSRegeneration.VC
Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.
AI & Machine LearningBiotech
PartnerDavid Harding· solo GP
Co-investorsUnruly CapitalSARAS CAPITALSemantic Ventures
Multus designs cell culture media for the industrial bioeconomy, applying AI, robotics, and biological expertise to media formulation.
AI & Machine LearningBiotechDeep TechFoodTechLondon, GB
Cai Linton(Founder)inKevin Pan(Founder)in
PartnerDavid Harding· solo GP
Co-investorsAsahi Kasei Corporate Venture CapitalBig Idea VenturesNourish VenturesSOSVZero Carbon CapitalMandi Ventures+1 more
Resurrect Bio develops more durable crop disease resistance by engineering plant immune receptors, combining plant molecular immunology, computational biology, AI, and high-throughput screening.
AgTechAI & Machine LearningBiotechLondon, GB
Cian Duggan(CEO & Co-Founder)inTolga Bozkurt(Co-Founder)inSophien Kamoun(Co-Founder)in
PartnerDavid Harding· solo GP
Co-investorsCalculus Capital Ltd.Future Planet CapitalGrowth Science VenturesPymwymicUK Innovation & Science Seed FundAgFunder
Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing.
AI & Machine LearningBiotechCleantech
PartnerDavid Harding· solo GP
Co-investorsClay CapitalFarvatn VenturePINCPlanet 9 CapitalSOSVAgFunder+1 more
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Founder)inIrsyad Khairil(Founder)in
PartnerDavid Harding· solo GP
Co-investorsHoxton VenturesLongeVCMetaplanetMK Venture CapitalOxonian VenturesP53 Invest+10 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.